Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history now includes a new revision entry, v3.5.5, following the previous v3.5.4, representing an updated version of the page history.
    Difference
    0.0%
    Check dated 2026-06-08T14:57:55.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release/patch was applied. This update relates to site metadata rather than changes to study data or visible content.
    Difference
    0.0%
    Check dated 2026-05-18T03:46:53.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now displays an updated “Revision” version number for the ClinicalTrials.gov interface (from v3.5.2 to v3.5.3). This represents a platform/version update rather than a modification to the trial record itself.
    Difference
    0.0%
    Check dated 2026-04-26T15:13:39.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 in the history log.
    Difference
    0.0%
    Check dated 2026-04-19T12:44:28.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.
    Difference
    0.0%
    Check dated 2026-03-21T08:47:03.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.4.3, was added and the previous Revision: v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-06T21:00:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.